Form 483

Srdan Verstovsek Form 483, 2017-08-11

FDA issued a Form 483 to Srdan Verstovsek on 2017-08-11 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Srdan Verstovsek · Houston, United States · Issued August 11, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Aug 2017
21 CFR 312.60

FD-1572, protocol compliance

Cited by Leighton K Ngai, Rachel M Skeete

11 Aug 2017
21 CFR 312.60

Informed consent

Cited by Leighton K Ngai, Rachel M Skeete

11 Aug 2017
21 CFR 312.62(a)

Accountability records

Cited by Leighton K Ngai, Rachel M Skeete

11 Aug 2017
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Leighton K Ngai, Rachel M Skeete

Inspected site

SVSrdan VerstovsekHouston, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations2x
21 CFR 312.62(a)Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere